Abstract
The function of the adrenal cortex is to produce the appropriate steroid hormones in normal amounts. Regulatory mechanisms both within the adrenal cell and within the hypothalamic-pituitary-adrenal axis normally ensure that this function is properly performed. Production of an inappropriate kind or amount of steroid hormone results in disease. Thus, it is not surprising that diseases of the adrenal cortex are frequently the result of primary abnormalities of regulation rather than of structure. The enzymatic pathways responsible for converting substrate cholesterol into steroid hormones have been well delineated for many years.1 On the other hand, regulation of these pathways and details of their molecular mechanisms are incompletely understood. It would seem that a more thorough and accurate understanding of these processes would lead to improved diagnosis and treatment of adrenal disorders. Thus, in the preparation of this review, the relationship of recently reported basic observations to current understanding of adrenal regulation has been emphasized. It is hoped that this approach will highlight the relevance of experimental observations to clinical questions. At the same time, the intent is to provide a sufficiently detailed review of basic observations to be of use to those with investigative interest in the adrenal cortex and the endocrine glands in general.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Temple, T.E., and Iiddle, G.W., 1970, Inhibitors of adrenal steroid biosynthesis, Annu. Rev. Pharmacol. 10: 199–218.
Schwyzer, R., 1977, ACTH: A short introductory review, Ann. N.Y. Acad. Sci. 297: 3–25.
Yalow, R.S., and Berson, S.A., 1971, Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH-producing thymoma, Biochem. Biophys. Res. Commun. 44: 439–445.
Orth, D.N., and Nicholson, W.E., 1977, Different molecular forms of ACTH, Ann. N.Y. Acad. Sci. 297: 27–48.
Orth, D.N., and Nicholson, W.W., 1977, High molecular weight forms of human ACTH are glycoproteins, J. Clin. Endocrinol. Metab. 44: 214–217.
Gewirtz, G., Schneider, B., Krieger, D.T., and Yalow, R.S., 1974, Big ACTH: Conversion to biologically active ACTH by trypsin, J. Clin. Endocrinol. Metab. 38: 227–230.
Eipper, B.A., and Mains, R.E., 1975, High molecular weight forms of adrenocorticotropic hormone in the mouse pituitary and in a mouse pituitary cell line, Biochemistry 14: 3836–3844.
Mains, R.E., and Eipper, B.A., 1976, Biosynthesis of adrenocorticotropic hormone in mouse pituitary tumor cells, J. Biol. Chem. 251: 4115–4120.
Roberts, J.L., and Herbert, E., 1977, Characterization of a common precursor to corticotropin and β-lipoprotein: Cell free synthesis of the precursor and identification of corticotropin peptides in the molecule, Proc. Natl. Acad. Sci. U.S.A. 74: 4826–4830.
Nakanishi, S., Taii, S., Hirata, Y., Matsukura, S., Imura, H., and Numa, S., 1976, A large product of cell-free translation of messenger RNA coding for corticotropin, Proc. Natl. Acad. Sci. U.S.A. 73: 4319–4323.
Lee, T.H., and Lee, M.S., 1977, Purification and characterization of high molecular weight forms of adrenocorticotropic hormone of ovine pituitary glands, Biochemistry 16: 2824–2829.
Eipper, B.A., Mains, R.E., and Guenzi, D., 1976, High molecular weight forms of adrenocorticotropin hormone are glycoproteins, J. Biol. Chem. 251: 4121–4126.
Lowry, P.J., Silman, R.E., and Hope, J., 1977, Structure and biosynthesis of peptides related to corticotropins and β-melanotropins, Ann. N.Y. Acad. Sci. 297: 49–62.
Moriarity, G.C., 1973, Adenohypophysis: Ultrastructural chemistry: A review, J. Histochem. Cytochem. 21: 855–894.
Pelletier, G., Leclerc, R., Labrie, F., Cote, J., Chretien, M., and Lis, M., 1977, Immunohistochemical localization of β-lipotropic hormone in the pituitary gland, Endocrinology 100: 770–776.
Golstein, A., Cox, B.M., Gentleman, S., Lowney, L.I., and Cheung, A.L., 1977, Pituitary and brain opioid peptides (endorphins), Ann. N.Y. Acad. Sci. 297: 108–114.
Guillemin, R., Ling, N., Lazarus, L., Burgus, R., Minick, S., Bloom, F., Nicoll, R., Siggins, G., and Segal, D., 1977, The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: Biochemical and biologic studies, Ann. N.Y. Acad. Sci. 297: 131–156.
Rubinstein, M., Stein, S., Gerber, L., and Undenfriend, S., 1977, Isolation and characterization of the opioid peptides from rat pituitary β-lipotropin, Proc. Natl. Acad. Sci. U.S.A. 74: 3052–3055.
Mains, R.E., Eipper, B.A., and Ling, N., 1977, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. U.S.A. 74: 3014–3018.
Jones, R.E., Pulkrabek, P., and Grunberger, D., 1977, Mouse pituitary tumor mRNA directed cell-free synthesis of polypeptides that are cross reactive with adrenocorticotropic hormone antiserum, Biochem. Biophys. Res. Commun. 74: 1490–1495.
Eipper, B.A., and Mains, R.E., 1977, Peptide analysis of a glycoprotein form of adrenocorticotropic hormone, J. Biol. Chem. 252: 8821–8832.
Liddle, G.W., Island, D., and Meador, C.K., 1962, Normal and abnormal regulation of corticotropin secretion in man, Recent Prog. Horm. Res. 18: 125–166.
Krieger, D., Amorosa, L., and Linick, F., 1975, Cyproheptadine-induced remission of Cushing’s disease, N. Engl. J. Med. 293: 893–896.
Krieger, D.T., Liotta, A., Suda, T., Palkovits, M., and Brownstein, M.D., 1977, Presence of immunoassayable β-lipotropin in bovine brain and spinal cord: Lack of concordance with ACTH concentrations, Biochem. Biophys. Res. Commun. 76(3): 930–936.
Krieger, D.T., Liotta, A., and Brownstein, M.J., 1977, Presence of corticotropin in brain of normal and hypophysectomized rats, Proc. Natl. Acad. Sci. U.S.A. 74(2): 648–652.
Sayers, G., 1977, Nature of corticotropin releasing factor, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2087.
Brodish, A., 1977, Tissue corticotropin releasing factor, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2088–2093.
Vale, W., and River, C., 1977, Substances modulating the secretion of ACTH by cultured anterior pituitary cells, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2094–2099.
Seelig, S., and Sayers, G., 1977, Bovine hypothalamic corticotropin releasing factor: Chemical and biological characteristics, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2100–2103.
Jones, M.T., Gellham, B., and Hillhouse E.W., 1977, The nature of corticotropin releasing factor from rat hypothalamus in vitro, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2104–2109.
Ganong, W.F., 1977, Neurotransmitters involved in ACTH secretion: Catecholamines, Ann. N.Y. Acad. Sci. 297: 509–517.
Jones, M.T., and Hillhouse, E.W., 1977, Neurotransmitter regulation of corticotropin-releasing factor in vitro, Ann. N.Y. Acad. Sci. 297: 536–558.
Vernikos-Danellis, J., Kellar, K.J., Kent, D., Gonzales, C., Berger, P.A., and Barchas, J.D., 1977, Serotonin involvement in pituitary-adrenal function, Ann. N.Y. Acad. Sci. 297: 518–526.
Krieger, D.T., 1977, Serotonin regulation of ACTH secretion, Ann. N.Y. Acad. Sci. 297: 527–535.
Fischer, J.L., and Moriarty, M., 1977, Control of bioactine corticotropin release from the neurointermediate lobe of the rat pituitary in vitro, Endocrinology 100: 1047–1054.
Krieger, D.T., 1977, Regulation of circadian periodicity of plasma ACTH levels, Ann. N.Y. Acad. Sci. 297: 561–567.
Seiden, G., and Brodish, A., 1972, Persistence of a diurnal rhythm in hypothalamic corticotropin-releasing factor (CRF) in the absence of hormone feedback, Endocrinology 90: 1401–1403.
Ixart, G., Szafarczyk, A., Belugou, J.L., and Assenmacher, I., 1977, Temporal relationships between the diurnal rhythm of hypothalamic corticotropin releasing factor, pituitary corticotrophin and plasma corticosterone in the rat, J. Endocrinol. 72: 113–120.
Dallman, M.F., and Yates, F.E., 1969, Dynamic asymmetries in the corticosteroid feedback path and distribution-metabolism-binding elements of the adrenocortical system, Ann. N.Y. Acad. Sci. 156: 696–721.
Jones, M.T., Tiptaft, E.M., Brush, F.R., Fergusson, D.A.N., and Neame, L.B., 1974, Evidence for dual corticosteroid-receptor mechanisms in the feedback control of adrenocorticotrophin secretion, J. Endocrinol. 60: 223–233.
Kendall, J.W., Scott, A.K., Allen, C., and Greer, M.A., 1966, Evidence for ACTH secretion and ACTH suppressibility in hypophysectomized rats with multiple heterotopic pituitaries, Endocrinology 78: 533–537.
Sayers, G., and Portanova, P., 1974, Secretion of ACTH by isolated anterior pituitary cells: Kinetics of simulation by corticotropin releasing factor and of inhibition by corticosterone, Endocrinology 94: 1723–1730.
Mims, R.B., 1973, Plasma ACTH in the adrenalectomized rat, Horm. Metab. Res. 5: 368–371.
Rees, L.H., Cook, D.M., Kendall, J.W., Allen, C.F., Kramer, R.M., Ratcliff, J.G., and Knight, R.A., 1971, A radioimmunoassay for rat plasma ACTH, Endocrinology 89: 254–261.
Nakanishi, S., Kita, T., Taii, S., Imura, H., and Numa, S., 1977, Glucocorticoid effect on the level of corticotropin messenger RNA activity in rat pituitary, Proc. Natl. Acad. Sci. U.S.A. 74: 3283–3286.
O’Malley, B.W., and Buller, R.E., 1976, Current concepts in steroid hormone action, in: The Year in Endocrinology 1975–1976 (S.H. Ingbar, ed.), pp. 277–315, Plenum Medical Book Company, New York.
Arimura, A., Bowers, C.Y., Schally, A.V., Saito, M., and Miller, M.C., III, 1969, Effect of corticotropin-releasing factor, dexamethasone and actinomycin D on the release of ACTH from rat pituitaries in vivo and in vitro, Endocrinology 85: 300–311.
Portanova, R., and Sayers, G., 1974, Corticosterone suppression of ACTH secretion: Actinomycin D sensitive and insensitive components of the response, Biochem. Biophys. Res. Commun. 56: 928–933.
Brattin, W.J., and Portanova, R., 1977, Corticosterone induction of pituitary hyperresponsiveness to CRF: Divergent effects of puromycin and cycloheximide, Mol. Cell. Endocrinol. 7: 221–231.
Mulder, G.H., and Smelik, P.G., 1977, A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamus-pituitary-adrenal system in vitro. I. Pituitary cell superfusion, Endocrinology 100: 1143–1152.
Vermes, I., Mulder, G.H., and Smelik, P.G., 1977, A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamic-pituitary-adrenal system in vitro. II. Hypothalamus-pituitary cell-adrenal cell superfusion, Endocrinology 100: 1153–1159.
Abe, K., and Critchlow, V., 1977, Effects of corticosterone, dexamethasone and surgical isolation of the medial basal hypothalamus on rapid feedback control of stress-induced corticotrophin secretion in female rats, Endocrinology 101: 498–505.
Jones, M.T., and Tiptaft, E.M., 1977, Structure-activity relationship of various corticosteroids on the feedback control of corticotrophin secretion, Br. J. Pharmacol. 59: 35–41.
Herbert, E., Allen, R.G., and Paquette, T.L., 1978, Reversal of dexamethasone inhibition of adrenocorticotropin release in a mouse pituitary tumor cell line either by growing cells in the absence of dexamethasone or by addition of hypothalamic extract, Endocrinology 102: 218–226.
Watanabe, H., Nicholson, W., and Orth, D., 1973, Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells, Endocrinology 93: 411–416.
Richardson, U.I., 1978, Self-regulation of adrenocorticotropin secretion by mouse pituitary tumor cells in cudture, Endocrinology 102: 910–917.
Kan, K.W., Baird, A., Seidah, N.G., Lis, M., Chretien, M., Ling, N., Guillemin, R., and Solomon, S., 1977, Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture, Biochem. Biophys. Res. Commun. 79: 553–560.
Holaday, J.W., Law, P.Y., Tseng, L.F., Loh, H.H., and Li, C.H., 1977, β-Endorphin: Pituitary and adrenal glands modulate its action, Proc. Natl. Acad. Sci. U.S.A. 74: 4628–4632.
Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W., and Bloom, F., 1977, β-Endorphin and adrenocorticotropin are secreted concomitandy by the pituitary gland, Science 197: 1367–1369.
Tanaka, K., Nicholson, W.E., and Orth, D.N., 1978, Diurnal rhythm and disappearance half-time of endogeneous plasma immunoreactive β-MSH (LPH) and ACTH in man, J. Clin. Endocrinol. Metab. 46: 883–890.
Abe, K., Nicholson, W.E., Iiddle, G.W., Island, D.D., and Orth, D.N., 1967, Radioimmunoassay of β-MSH in human plasma and tissues, J. Clin. Invest 46: 1609–1616.
Abe, K., Nicholson, W.E., Iiddle, G.W., Orth, D.N., and Island, D.P., 1969, Normal and abnormal regulation of β-MSH in man, J. Clin. Invest. 48: 1580–1585.
Sabol, S.L., 1978, Regulation of endorphin production by glucocorticoids in cultured pituitary tumor cells, Biochem. Biophys. Res. Commun. 82: 560–567.
Besser, G.M., Orth, D.N., Nicholson, W.E., Byyny, R.L., Abe, K., and Woodham, J.P., 1971, Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man, J. Clin. Endocrinol. Metab. 32: 595–603.
Meakin, J.W., Tingey, W.H., Jr., and Nelson, D.H., 1960, The catabolism of adrenocorticotropic hormone: The stability of adrenocorticotropic hormone in blood, plasma, serum and saline, Endocrinology 66: 59–72.
McMartin, C., and Peters, J., 1975, Levels of corticotrophin analogues in the blood after infusion into rats, J. Endocrinol. 67: 41–48.
Baker, J.R.J., Bennett, H.P.J., Hudson, A.M., McMartin, C., and Purdon, G.E., 1976, On the metabolism of two adrenocorticotrophin analogues, Clin. Endocrinol. 5 (Suppl.), pp. 61s–72s.
Keenan, J., Thompson, J.B., Chamberlain, M.A., and Besser, G.M., 1971, Prolonged corticotrophic action of a synthetic substituted 1–18ACTH, Br. Med. J. 3: 742–743.
Baker, J.R.J., Bennett, H.P.J., Christian, R.A., and McMartin, C., 1977, Renal uptake and metabolism of adrenocorticotropin analogues in the rat: An autoradiographic study, J. Endocrinol. 74: 23–35.
Varandani, P.T., and Shroyer, L.A., 1977, A rat kidney neutral peptidase that degrades B chain of insulin, glucagon, and ACTH: Purification by affinity chromatography and some properties, Arch. Biochem. Biophys. 181: 82–93.
Jeffcoate, W.J., Phenekos, C., Ratcliffe, J.G., Williams, S., Rees, L., and Besser, G.M., 1977, Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: α1–24 and substituted α1–18 ACTH, Clin. Endocrinol. 7: 1–11.
McMartin, C., Purdon, G.E.E., Schenkel, L., Desaulles, P., Maier, R., Brugger, M., Rittel, W., and Sieber, P., 1977, Differences between in-vitro and in-vivo potencies of corticotrophins: An interpretation in terms of metabolic stability, J. Endocrinol. 73: 79–89.
Van Nispen, J.W., Tesser, G.I., Barthe, P.L., Maier, R., and Schenkel-Hulliger, L., 1977, Biological activities of ACTH analogues varied in the active site, Acta Endocrinol. 84: 470–484.
Finn, F., Johns, P., Nishi, N., and Hofman, K., 1976, Differential response to adrenocorticotropin hormone analogs of bovine adrenal plasma membrane and cells, J. Biol. Chem. 251: 3576–3585.
Hofman, K., Andreatta, R., Bohn, K., and Morodor, L., 1970, Studies on polypeptides. XLV. Structure function studies in the β-corticotropin series, J. Med. Chem. 13: 339–345.
Garren, L.D., Ney, R.L., and Davis, W.W., 1965, Studies on the role of protein synthesis in the regulation of corticosterone production by adrenocorticotropic hormone in vivo, Proc. Natl. Acad. Sci. U.S.A. 53: 1443–1450.
Beall, R.J., and Sayers, G., 1972, Isolated adrenal cells: Steroidogenesis and cyclic AMP accumulation in response to ACTH, Arch. Biochem. Biophys. 148: 70–76.
Moyle, W.R., Kong, Y.C., and Ramachandran, J., 1973, Steroidogenesis and cyclic adenosine 3′,5′-monophosphate accumulation in rat adrenal cell, J. Biol. Chem. 248: 2409–2417.
Schimmer, B.P., Tsao, J., and Knapp, M., 1977, Isolation of mutant adrenocortical tumor cells resistant to cyclic nucleotides, Mol. Cell. Endocrinol. 8: 135–145.
Riou, J.P., Evain, D., Perrin, F., and Saez, J.M., 1977, Adenosine 3′5′-cyclic monophosphate dependent protein kinase in human adrenocortical tumors, J. Clin. Endocrinol. Metab. 44: 413–419.
Hornsby, P.J., and Gill, G.N., 1977, Hormonal control of adrenocortical cell proliferation: Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures, J. Clin. Invest. 60: 342–352.
Hornsby, P.J., and Gill, G.N., 1978, Characterization of adult bovine adrenocortical cells throughout their life span in tissue culture, Endocrinology 102: 926–936.
Rubin, R.P., Laychock, S.G., and End, D.W., 1977, On the role of cyclic AMP and cyclic GMP in steroid production by bovine cortical cells, Biochem. Biophys. Acta 496: 329–338.
Perchellet, J.P., Shanker, G., and Sharma, R.K., 1978, Regulatory role of guanosine 3′,5′-monophosphate in adrenocorticotropin hormone-induced steroidogenesis, Science 199: 311–312.
Honn, K.V., and Chavin, W., 1977, In vitro temporal cAMP and cortisol responses to ACTH by the normal human adrenal gland, Acta Endocrinol. 85: 823–831.
Schlegel, W., and Schwyzer, R., 1977, Purification of bovine adrenal-cortex plasma-membrane vesicles containing a highly corticotropin-sensitive adenylate-cyclase system and angiotensin-II-binding sites, Eur. J. Biochem. 72: 415–424.
Rodbell, M., Birnbaumer, L., Pohl, S.L., and Krans, M.J., 1971, The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanyl nucleotides in glucagon action, J. Biol. Chem. 246: 1877–1882.
Glynn, P., Cooper, D.M.F., and Schulster, D., 1977, Control of bovine adrenocortical adenylate cyclase activity by guanine nucleotides, Biochem. Soc. Trans. 5: 973–975.
Rodbell, M., Lin, M.C., Salomon, Y., Londos, C., Harwood, J.P., Martin, B.R., Rendell, M., and Berman, M., 1975, Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: Evidence for multisite transition states, Adv. Cyclic Nucleotide Res. 5: 3–29.
Bonnafous, J.C., Fauchere, J.L., Schlegel, W., and Schwyzer, R., 1977, Hormone-receptor interactions: Stimulation and inhibition of bovine adrenal cortex cell membrane adenylate cyclase by synthetic corticotropin fragments and the effect of 5′-guanylylimidodiphosphate, FEBS Lett. 78: 247–250.
Glossman, H., and Struck, C.J., 1977, Adrenal cortex adenylate cyclase: In vitro modification of the enzyme by cholera toxin, Naunyn-Schmiedeberg’s Arch. Pharmacol. 299: 175–185.
Mahaffee, D., Reitz, R.C., and Ney, R.I., 1974, The mechanism of action of adrenocorticotropic hormone: The role of mitochondrial cholesterol accumulation in the regulation of steroidogenesis, J. Biol. Chem. 249: 227–233.
Paul, D.P., Gallant, S., Orime-Johnson, J.R., and Brownie, A.C., 1976, Temperature dependence of cholesterol binding to cytochrome P-450SCC of the rat adrenal: Effect of corticotropic hormone and cycloheximide, J. Biol. Chem. 251: 7120–7126.
Tilley, B.E., Watanuki, M., and Hall, P.F., 1977, Preparation and properties of side-chain cleavage cytochrome P-450 from bovine adrenal cortex by affinity chromatography with pregnenolone as ligand, Biochim. Biophys. Acta 493: 260–271.
Watanuki, M., Tilley, B.E., and Hall, P.F., 1977, Purification and properties of cytochrome P-450 (11β-and 18-hydroxylase) from bovine adrenocortical mitochondria, Biochem. Biophys. Acta 483: 236–427.
Wang, H.P., and Kimura, T., 1976, Purification and characterization of adrenal cortex mitochondrial cytochrome P-450 specific for cholesterol side chain cleavage activity, J. Bid. Chem. 251: 6068–6074.
Shikita, M., and Hall, P.F., 1973, Cytochrome P-450 from bovine adrenocortical mitochondria: An enzyme for the side chain cleavage of cholesterol. I. Purification and properties, J. Biol. Chem. 248: 5598–5604.
Tilley, B.E., Watanuki, M., and Hall, P.F., 1977, Side-chain cleavage P-450 from bovine adrenocortical mitochondria: Reconstitution of enzyme activity, Biochem. Biophys. Acta 488: 330–339.
Watanuki, M., Granger, G.A., and Hall, P.F., 1978, Cytochrome P-450 from bovine adrenocortical mitochondria. Immunochemical properties and purity, J. Biol. Chem. 253: 2927–2931.
Jefcoate, C.R., 1977, Cytochrome P-450 of adrenal mitochondria: Steroid binding sites on two distinguishable forms of rat adrenal mitochondrial cytochrome P-450SCC, J. Biol Chem. 252: 8788–8796.
Björkhem, I., and Karlmar, K.E., 1977, Common characteristics of the cytochrome P-450 system involved in 18-and 11β-hydroxylation of deoxycorticosterone in rat adrenals, J. Lipid Res. 18: 592–603.
Moustafa, A.M., and Koritz, S.B., 1977, Studies on the stimulation by Ca2+ and the inhibition by ADP of steroid 11β-hydroxylation in adrenal mitochondria, Eur. J. Biochem. 78: 231–238.
Simpson, E.R., McCarthy, J.L., and Peterson, J.A., 1978, Evidence that the cydoheximide sensitive site of adrenocorticotropic hormone action is in the mitochondrion, J. Biol. Chem. 253: 3135–3139.
Farese, R.V., and Prudente, W.J., 1977, On the requirement for protein synthesis during corticotropin-induced stimulation of cholesterol side chain cleavage in rat adrenal mitochondrial and solubilized desmolase preparations, Biochim. Biophys. Acta 496: 567–570.
Koritz, S.B., and Kumar, A.M., 1970, On the mechanism of action of the adrenocorticotrophic hormone. The stimulation of the activity of enzymes involved in pregnenolone synthesis, J. Biol. Chem. 245: 152–159.
Andersen, J.M., and Dietschy, J.M., 1976, Regulation of sterol synthesis in adrenal gland of the rat by both high and low density human plasma lipoproteins, Biochem. Biophys. Res. Commun. 72: 880–885.
Andersen, J.M., and Dietschy, J.M., 1977, Regulation of sterol synthesis in 16 tissues of rat. I. Effect of diurnal light cycling, fasting, stress, manipulation of enterohapatic circulation and administration of chylomicrons and triton, J. Biol. Chem. 252: 3646–3651.
Andersen, J.M., and Dietschy, J.M., 1977, Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteine and of rat chylomicrons remnants, J. Biol. Chem. 252: 3652–3659.
Balasubramaniam, S., Goldstein, J.L., Faust, J.R., Brunschede, G.Y., and Brown, M.S., 1977, Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat, J. Biol. Chem. 252: 1771–1779.
Balasubramanian, S., Goldstein, J.L., and Brown, M.S., 1977, Regulation of cholesterol synthesis in rat adrenal gland through coordinate control of 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase activities. Proc. Natl Acad. Sci. U.S.A. 74: 1421–1425.
Brecher, P.I., and Hyun, Y., 1978, Effect of 4-aminopyrazolopyrimidine and aminoglutethimide on cholesterol metabolism and steroidogenesis in the rat adrenal, Endocrinology 102: 1404–1413.
Gwynne, J.T., and Hess, B., 1979, Role of high density lipoproteins in rat adrenal steroidogenesis and cholesterol metabolism (submitted).
Gwynne, J.T., and Hess, B., 1978, Binding and degradation of human 12I-HDL by rat adrenocortical cells, Metabolism 27: 1593–1600.
Gwynne, J.T., Hughes, T., Roundtree, R., and Hess, B., 1979, Properties and ACTH regulation of the HDL receptors of the rat adrenal cortex (submitted).
Faust, J.R., Goldstein, J.L., and Brown, M.S., 1977, Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells, J. Biol. Chem. 252: 4861–4871.
Brown, M.S., and Goldstein, J.L., 1976, Receptor mediated control of cholesterol metabolism, Science 191: 150–154.
Naghshineh, S., Treadwell, C.R., Gallo, L., and Vahouny, G.V., 1974, Activation of adrenal steroid ester-hydroylase by dibutyryl cAMP and protein kinase, Biochem. Biophys. Res. Commun. 61: 1076–1082.
Trzeciak, W.H., and Boyd, G.S., 1974, Activation of cholesteryl esterase in bovine adrenal cortex, Eur. J. Biochem. 46: 201–207.
Beckett, G.J., and Boyd, G.S., 1977, Purification and control of bovine adrenal cortical cholesterol ester hydrolase and evidence for the activation of the enzyme by a phosphorylation, Eur. J. Biochem. 72: 223–233.
Cortese, F., and Wolff, J., 1978, Cytochalasin-stimulated steroidogenesis from high density lipoproteins, J. Cell. Biol. 77: 507–516.
Mrotek, J.J., and Hall, P.F., 1975, The influence of cytochalasin B on the response of adrenal tumor cells to ACTH and cyclic AMP, Biochem. Biophys. Res. Commun. 64: 891–896.
Mrotek, J.J., and Hall, P.F., 1977, Response of adrenal tumor cells to adrenocorticotropin: Site of inhibition by cytochalasin B, Biochemistry 16: 3177–3181.
Hadjian, A.J., Guidicelli, C., and Chambaz, E.M., 1977, Characterization of tubulin in the bovine adrenal cortex cytosol, FEBS Lett. 77: 233–238.
Strott, C.A., and Ray, P., 1977, Studies of a colchicine-binding protein (tubulin) in the adrenal cortex and brain, Biochim. Biophys. Acta 495: 119–128.
Temple, R., and Wolff, J., 1973, Stimulation of steroid secretion by antimicrotubular agents, J. Biol. Chem. 248: 2691–2698.
O’Hare, M.J., 1976, Monolayer cultures of normal adult rat adrenocortical cells: Steroidogenic responses to nucleotides, bacterial toxins and antimicrotubular agents, Experientia 32: 251–253.
Liddle, G.W., 1960, Tests of pituitary adrenal suppressibility in the diagnosis of Cushing’s syndrome, J. Clin. Endocrinol. Metab. 20: 1539–1560.
Liddle, G.W., Estep, H.L., Kendall, J.W., Williams, W.C., Jr., and Townes A.W., 1959, Clinical application of a new test of pituitary reserve, J. Clin. Endocrinol. Metab. 19: 875–894.
Besser, G.M., 1973, ACTH and MSH assays and their clinical application, Clin. Endocrinol. 2: 175–186.
Similä, S., Kauppila, A., Ylikorkala, O., Koivisto, M., Mäkelä, P., and Haapalahti, J., 1977, Adrenocorticotrophic hormone during the first day of life, Eur. J. Pediatr. 124: 173–177.
Winters, A.J., Oliver, C., Colston, C., MacDonald, P.C., and Porter, J.C., 1974, Plasma ACTH levels in the human fetus and neonate as related to age and parturition, J. Clin. Endocrinol. Metab. 39: 269–273.
Berson, S.A., and Yalow, R.S., 1968, Radioimmunoassay of ACTH in plasma, J. Clin. Invest. 47: 2725–2751.
Miyakawa, I., Ikeda, I., and Maeyama, M., 1974, Transport of ACTH across human placenta, J. Clin. Endocrinol. Metab. 39: 440–442.
Allen, J.P., Cook, D.M., Kendall, J.W., and McGilvra, R., 1973, Maternal-fetal ACTH relationship in man, J. Clin. Endocrinol. 37: 230–234.
Liotta, A., Osathanondh, R., Ryan, K.J., and Krieger, D.T., 1977, Presence of corticotropin in human placenta: Demonstration of in vivo synthesis, Endocrinology 101: 1552–1558.
Kauppila, A., Similä, S., Ylikorkala, O., Koivisto, M., Mäkelä, P., and Haapalahti, J., 1976, ACTH levels in maternal, fetal and neonatal plasma, after short term prenatal dexamethasone therapy, Br. J. Obstet. Gynecol. 84: 124–128.
Schmidt, I.G., and Hoffman, R.G., 1954, Effects of ACTH on pregnant monkeys and their offspring, Anat. Rec. 118: 351–352.
West, C.D., and Dolman, L.I., 1977, Plasma ACTH radioimmunoassay in the diagnosis of pituitary-adrenal dysfunction, Ann. N.Y. Acad. Sci. 297: 205–219.
Jubiz, W., Meikle, A.W., West, C.D., and Tyler, F.H., 1970, Single-dose metyrapone test, Arch. Intern. Med. 125: 472–474.
Schoneshofer, M., L’age, M., and Oelkers, N., 1977, Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test, Acta Endocrinol. 85: 109–117.
Nishida, S., Matsumura, S., Horino, M., Oyama, H., and Tenku, A., 1977, The variations of plasma corticosterone/cortisol ratios following ACTH stimulation or dexamethasone administration in normal men, J. Clin. Endocrinol. Metab. 45: 585–588.
Kolanowski, J., Esselinckx, W., Nagant, C., and Crabbe, J., 1977, Adrenocortical response upon repeated stimulation with corticotrophin in patients lacking endogenous corticotrophin secretion, Acta Endocrinol. 85: 595–607.
Besser, G., and Landon, J., 1968, Plasma levels of immunoreactive corticotrophin in patients with Cushing’s syndrome, Br. Med. J. 4: 552–554.
Gilkes, J.J.H., Rees, L.H., and Besser, G.M., 1977, Plasma immunoreactive corticotrophin and lipotrophin in Cushing’s syndrome and Addison’s disease, Br. Med. J. 1: 996–998.
Hankin, M.E., Theile, H.M., and Steinbeck, A.W., 1977, An evaluation of laboratory tests for the detection and differential diagnosis of Cushing’s syndrome, Clin. Endocrinol. 6: 185–196.
Perlstein, R., Kopp, L., and Tucci, J.R., 1977, The effect of pituitary adrenal manipulations upon urinary cyclic AMP excretion in man, Acta Endocrinol. 84: 343–348.
Cushing, H., 1932, The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism), Bull. Johns Hopkins Hosp. 50: 137–195.
Plotz, C.M., Knowlton, A.I., and Ragan, C., 1952, The natural history of Cushing’s syndrome, Am. J. Med. 13: 597–614.
Tyrrell, J.B., Brooks, R.M., Fitzgerald, P.A., Cofoid, P.B., Forsham, P.H., and Wilson, C.B., 1978, Cushing’s disease: Selective trans-sphenoidal resection of pituitary microadenomas, N. Engl. J. Med. 298: 753–758.
Salassa, R.M., Laws, E.R., Carpenter, P.C., and Northcutt, R.C., 1978, Transphenoidal removal of pituitary microadenoma in Cushing’s disease, Mayo Clin. Proc. 53: 24–28.
Krieger, D.T., Amorosa, L., and Iinick, F., 1975, Cyproheptadine-induced remission of Cushing’s disease, N. Engl. J. Med. 293: 893–896.
Krieger, D.T., and Condon, E.M., 1978, Cyproheptadine treatment of Nelson’s syndrome: Restoration of plasma ACTH circadian periodicity and reversal of response to TRF, J. Clin. Endocrinol. Metab. 46: 349–351.
Krieger, D.T., and Luria, M., 1977, Plasma ACTH and cortisol responses to TRF, vasopressin, or hypoglycemia in Cushing’s disease and Nelson’s syndrome, J. Clin. Endocrinol. Metab. 44: 361–368.
Krieger, D., and Glick, S.M., 1972, Growth hormone and cortisol responsiveness in Cushing’s syndrome, Am. J. Med. 52: 25–40.
James, V.H.T., Landon, J., Wynn, V., and Greenwood, F.C., 1968, A fundamental defect of adrenocortical control in Cushing’s disease, J. Endocrinol. 40: 15–28.
Tyrrell, J.B., Wiener-Kronish, J., Lorenzi, M., Brooks, R.M., and Forsham, P.H., 1977, Cushing’s disease: Growth hormone response to hypoglycemia after correction of hypercortisolism, J. Clin. Endocrinol. Metab. 44: 218–220.
Demura, R., Demura, H., Nunokawa, T., Baba, H., and Miura, K., 1972, Responses of plasma ACTH, GH, LH, and 11-hydroxycorticosteroids to various stimuli in patients with Cushing’s syndrome, J. Clin. Endocrinol. Metab. 34: 852–859.
Lamberts, S.W.J., Timmermans, H.A.T., de Jong, F.H., and Birkenhager, J.C., 1977, The role of dopaminergic depletion in the pathogenesis of Cushing’s disease and the possible consequences for medical therapy, Clin. Endocrinol. 7: 185–193.
Wilber, J.F., and Utiger, R.D., 1969, The effect of glucocorticoids on thyrotropin secretion, J. Clin. Invest. 48: 2096–2103.
Smals, A.G.H., Kloppenborg, P.W.C., and Benraad, T.J., 1977, Plasma testosterone profiles in Cushing’s disease, J. Clin. Endocrinol. Metab. 45: 240–245.
Luton, J.P., Thieblot, P., Valcke, J.C., Mahoudeau, J.A., and Bricare, H., 1977, Reversible gonadotropin deficiency in male Cushing’s disease, J. Clin. Endocrinol. Metab. 45: 488–495.
Boccuzzi, G., Angeli, A., Bisbocci, D., Fonzo, D., Gaidano, G.P., and Ceresa, F., 1975, Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing’s disease, J. Clin. Endocrinol. Metab. 40: 892–895.
Orth, D.N., and Liddle, G.W., 1971, Results of treatment in 108 patients with Cushing’s syndrome, N. Engl. J. Med. 285: 243–247.
Moore, T.J., Dluhy, R.G., Williams, G.H., and Cain, J.P., 1976, Nelson’s syndrome: Frequency, prognosis, and effect of prior pituitary irradiation, Ann. Intern. Med. 85: 731–734.
Jennings, A.S., Liddle, G.W., and Orth, D.N., 1977, Results of treating childhood Cushing’s disease with pituitary irradiation, N. Engl. J. Med. 297: 957–962.
Scott, H.W., Liddle, G.W., Mulherin, J.L., McKenna, T.J., Stroup, S.L., and Rhamy, R.K., 1977, Surgical experience with Cushing’s disease, Ann. Surg. 185: 524–534.
Krieger, D.T., and Luria, M., 1976, Effectiveness of cyproheptadine in decreasing plasma ACTH concentration in Nelson’s syndrome, J. Clin. Endocrinol. Metab. 43: 1179–1181.
Hardy, J., 1975, Trans-sphenoidal microsurgical removal of pituitary micro-adenoma, Prog. Neurol. Surg. 6: 200–216.
Carmalt, M.H.B., Dalton, G.A., Fletcher, R.F., and Smith, W.T., 1977, The treatment of Cushing’s disease by trans-sphenoidal hypophysectomy, Q.J. Med. 46: 119–134.
Daughaday, W.H., 1978, Cushing’s disease and basophilic microadenomas (editorial), N. Engl. J. Med. 298: 793–794.
Jeffcoate, W.J., Rees, L.H., Tomlin, S., Jones, A.E., Edwards, C.R.W., and Besser, G.M., 1977, Metyrapone in long-term management of Cushing’s disease, fir. Med. J. 2: 215–217.
Orth, D.N., 1978, Metyrapone is useful only as adjunctive therapy in Cushing’s disease, Ann. Intern. Med. 89: 128–130.
Zachmann, M., Gitzelmann, R.P., Zagalak, M., and Prader, A., 1977, Effects of aminoglutethimide on urinary cortisol and cortisol metabolites in adolescents with Cushing’s syndrome, Clin. Endocrinol. 7: 63–71.
Bartter, F.C., 1977, Adrenogenital syndromes: From physiology to chemistry (1950–1975), in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 9–18, University Park Press, Baltimore.
Bongiovanni, A.M., and Eberlain, W.R., 1958, Defective steroidal biogenesis in congenital adrenal hyperplasia, Pediatrics 21: 661–672.
Kowarski, A., Finkelstein, J.W., Spaulding, J.S., Holman, G.H., and Migeon, C., 1965, Aldosterone secretion rate in congenital adrenal hyperplasia: A discussion of the theories on the pathogenesis of the salt-losing form of the syndrome, J. Clin. Invest. 44: 1505–1513.
New, M.I., Miller, B., and Peterson, R.E., 1966, Aldosterone excretion in normal children and in children with adrenal hyperplasia, J. Clin. Invest. 45: 412–428.
Kowarski, A.A., 1977, Mechanism of salt losses in congenital virilizing adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 113–124, University Park Press, Baltimore.
Bartter, F.C., Henkin, R.I., and Bryan, G.T., 1968, Aldosterone hypersecretion in “non-salt losing” congenital adrenal hyperplasia, J. Clin. Invest. 47: 1742–1752.
Godard, C., Riondel, A., Veyrat, R., Megevand, A., and Muller, A.F., 1968, Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia, Pediatrics 41: 883–896.
Strickland, A.L., and Kotchen, T.A., 1972, A study of the renin-aldosterone system in congenital adrenal hyperplasia, J. Pediatr. 81: 962–969.
Hughes, I.A., and Winter, J.S.D., 1977, 17-Hydroxyprogesterone and plasma renin activity in congenital adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 141–156, University Park Press, Baltimore.
Strott, C.A., Yoshimi, T., and Lipsett, M.B., 1969, Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia, J. Clin. Invest. 48: 930–939.
Hughes, I.A., and Winter, J.S.D., 1976, The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia, J. Pediatr. 88: 766–773.
McKenna, T.J., Jennings, A.S., Liddle, G.W., and Burr, I.M., 1976, Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 42: 918–925.
Janoski, A., 1977, Naturally occurring adrenal steroids with salt-losing properties, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.) pp. 99–112, University Park Press, Baltimore.
Pham-Huu-Trung, M.T., Raux, M.C., Gourmelen, M., Baron, M., and Girard, F., 1976, Plasma aldosterone concentrations related to 17 α-hydroxyprogesterone in congenital adrenal hyperplasia, Acta. Endocrinol. 82: 572–586.
Parth, K., Zimprich, H., Swoboda, W., Brunei, R., and Bohrn, E., 1978, Congenital adrenal hyperplasia: Simultaneous determinations of plasma aldosterone and 17-hydroxyprogesterone, Acta Endocrinol. 87: 148–157.
Limai, J.M., Rappaport, R., and Bayard, F., 1977, Plasma aldosterone, renin activity and 17 α-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effects of 9α-fluorocortisol, J. Clin. Endocrinol. Metab. 45: 551–559.
Rosier, A., Levine, L.S., Schneider, B., Novogroder, M., and New, M.I., 1977, The interrelationship of sodium balance, plasma renin activity and ACTH on congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 45: 500–512.
Rayyis, S.S., and Horton, R., 1971, Effect of angiotensin II on adrenal and pituitary function in man, J. Clin. Endocrinol. Metab. 32: 539–546.
Hepp, R., Grillet, C., Peytremann, A., and Vallotton, M.B., 1977, Stimulation of corticosteroid biosynthesis by angiotensin I, [Des-Asp1]angiotensin I, angiotensin II and [Des-Asp1]angiotensin II in bovine adrenal fasciulata cells, Endocrinology 101: 717–725.
Gill, A., Ill, C.R., and Simonian, M.H., 1977, Angiotensin stimulation of bovine adrenocortical cell growth, Proc. Natl. Acad. Sci. U.S.A. 74: 5569–5573.
Beitins, I.Z., Bayard, F., Kowarski, A., and Migeon, C.J., 1972, The effect of ACTH administration on aldosterone production in non-salt losing congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 35: 595–603.
Douglas, J., Aguilera, G., Kondo, T., and Catt, K., 1978, Angiotensin II receptors and aldosterone production in rat adrenal glomerulosa cells, Endocrinology 102: 685–696.
Klingensmith, G.J., Garcia, S.C., Jones, H.W., Migeon, C.J., and Blizzard, R.M., 1977, Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effects on height, sexual maturation, and fertility. J. Pediatr. 90: 996–1004.
Pang, S., Kenny, F.M., Foley, T.P., and Drash, A.L., 1977, Growth and sexual maturation in treated congenital adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 233–246, University Park Press, Baltimore.
Ghali, I., David, M., and David, L., 1977, Linear growth and pubertal development in treated congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Clin. Endocrinol. 6: 425–436.
Styne, D.M., Richards, G.E., Bell, J.J., Conte, F.A., Morishema, A., Kaplan, S.L., and Grumback, M.M., 1977, Growth patterns in congenital adrenal hyperplasia: Correlation of glucocortiod therapy with stature, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 247–261, University Park Press, Baltimore.
Huseman, C.A., Varma, M.M., Blizzard, R.M., and Johanson, A., 1977, Treatment of congenital virilizing adrenal hyperplasia patient with single and multiple daily doses of prednisone, J. Pediatr. 90: 538–542.
Bacon, G.E., Spencer, M.L., and Kelch, R.P., 1977, Effect of cortisol treatment on hormonal relationships in congenital adrenal hyperplasia, Clin. Endocrinol. 6: 113–126.
Korth-Schutz, S., Virdis, R., Saenger, P., Chow, D.M., Levine, L.S., and New, M.I., 1978, Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 46: 452–458.
Roux, H., Loras, B., and Forest, M.G., 1977, Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: Plasma I7α-hydroxyprogesterone in patients’ relatives, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 487–494, University Park Press, Baltimore.
Knorr, D., Bidlingmaier, F., Butenandt, O., von Schnakenburg, K., and Wagner, W., 1977, Tests for heterozygosity of congenital adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 495–500, University Park Press, Baltimore.
Gutai, J.P., Kowarski, A.A., and Migeon, C.J., 1977, The detection of the heterozygous carrier for congenital virilizing adrenal hyperplasia, J. Pediatr. 90: 924–929.
Gutai, J.P., Kowarski, A.A., and Migeon, C.J., 1977, Detection of heterozygote carrier for congenital virilizing adrenal hyperplasia, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 501–508, University Park Press, Baltimore.
Krensky, A.M., Bongiovanni, A.M., Marino, J., Parks, J., and Tenore, A., 1977, Identification of heterozygote carriers of congenital adrenal hyperplasia by radioimmunoassay of serum 17-OH progesterone, J. Pediatr. 90: 930–933.
Homoki, J., Fazekas, A.T.A., and Tiller, W.M., 1977, Urinary excretion of pregnanetriolone in parents of children with 21-hydroxylase deficiency before and after stimulation with adrenocorticotropic hormone, in: Congenital Adrenal Hyperplasia (P.A. Lee, L.P. Plotnick, A.A. Kowarski, and C.J. Migeon, eds.), pp. 479–486, University Park Press, Baltimore.
Koizumi, S., Kyoya, S., Miyawaki, T., Kidani, H., Funabashi, T., Nakashima, H., Nakanuma, Y., Otha, G., Itagaki, E., and Katagiri, M., 1977, Cholesterol side-chain cleavage enzyme activity and cytochrome P-450 content in adrenal mitochondria of a patient with congenital lipoid adrenal hyperplasia, Clin. Chim. Acta 77: 301–306.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gwynne, J.T., Ney, R.L. (1979). The Adrenal Cortex. In: Ingbar, S.H. (eds) Contemporary Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4857-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4857-4_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4859-8
Online ISBN: 978-1-4757-4857-4
eBook Packages: Springer Book Archive